MedWatch

Lundbeck aims for further growth after record year

Danish drug group Lundbeck rejects market rumors of a quiet fourth quarter of a record year. And the company plans for more growth in 2018 generated by China and a European turnaround.

Photo: /ritzau/Jeppe Bøje Nielsen

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

William Demant går mod trenden i jagt på fortsat vækst

Når storproducenten af høreapparater William Demant om få uger lancerer en stribe nye produkter, vil der være tale om nye tilbud til kunderne, der ellers går mod den globale trend, hvor høreapparatets elektronik placeres bag øret.

Related articles